Hospitals and clinics Segment to Dominate MEA swabs collection kit market During 2021–2028

According to a new market research study on “MEA swabs collection kit market to 2028 – COVID-19 Impact Analysis and Forecast by Type, by Application, and Country” is expected to reach US$ 281.46 million by 2028 from US$ 222.41 million in 2021. The market is estimated to grow at a CAGR of 3.4% from 2021 to 2028. The report provides trends prevailing in the MEA swabs collection kit market along with the drivers and restraints pertaining to the market growth. Enlarging number of coronavirus cases and high need for accurate and modern swab collection kits are the major factor driving the growth of the MEA swabs collection kit market. However, inadequacy of expertise and limitation of swab collection kits hinders the growth of MEA swabs collection kit market.    

The MEA swabs collection kit market is segmented based on by type, by application, and country. Based on type, the MEA swabs collection kit market is segmented into nasopharyngeal swabs, oropharyngeal swabs, and others. The nasopharyngeal swabs dominated the MEA swabs collection kit market in 2020. Based on application, the MEA swabs collection kit market is segmented into microbiology laboratories, diagnostic laboratories, hospitals and clinics, home tests, and others. The hospitals and clinics segment dominated the MEA swabs collection kit market in 2020. Based on country, the MEA swabs collection kit market is segmented into Saudi Arabia, South Africa, UAE, and Rest of MEA. The UAE segment dominated the MEA swabs collection kit market in 2020.   

BD; Puritan Medical Products Company LLC; Laboratory Corporation of America Holdings; HiMedia Laboratories; THERMO FISHER SCIENTIFIC INC.; Hardy Diagnostics; VIRCELL S.L; BTNX, Inc; Formlabs; Quidel Corporation; DiaSorin S.P.A; Norgen Biotek Corp; Hologic, Inc; Quest Diagnostics Incorporated; Abbott; Lynn Peavey Company; and QIAGEN by Altair are among the leading companies in the MEA swabs collection kit market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2020, Hardy Diagnostics had exponentially increased manufacturing production in order to supply customers with critical laboratory products during the COVID-19 pandemic. Specifically, Hardy had increased production of Viral Transport Medium (VTM, Cat. No. R99), a product recommended by the CDC for collection and transportation of specimens from patients suspected of a COVID-19 infection.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com